48 results on '"Bouvier, Catherine"'
Search Results
2. Impact of neuroendocrine morphology on cancer outcomes and stage at diagnosis: a UK nationwide cohort study 2013–2015
3. The Role of Patient Support Groups in Neuroendocrine Neoplasms
4. Delays and routes to diagnosis of neuroendocrine tumours
5. Incidence and survival of neuroendocrine neoplasia in England 1995–2018: A retrospective, population-based study
6. Second primary malignancies in patients with a neuroendocrine neoplasm in England
7. The impact of COVID‐19 on the management of neuroendocrine tumors (NETS): An international NET CONNECT survey of NET patients and healthcare professionals treating net patients
8. Global challenges in access to diagnostics and treatment for neuroendocrine tumor (NET) patients.
9. ‘A New World, a New Way of Seeing’: The Role of Paper Conservation Training in the Professionalization of the Field
10. Consensus on molecular imaging and theranostics in neuroendocrine neoplasms
11. Survey of Challenges in Access to Diagnostics and Treatment for Neuroendocrine Tumor (NET) Patients (SCAN) – application of surgery in treatment of SI NETs
12. Survey of challenges in access to diagnostics and treatment for neuroendocrine tumor patients (SCAN): The diagnostic process of GEP-NETs in Australia, Canada, China, France, Germany, the United Kingdom, and the United States of America.
13. The TrkC Receptor Induces Apoptosis When the Dependence Receptor Notion Meets the Neurotrophin Paradigm
14. Addressing professional development needs in neuroendocrine cancer nursing
15. Incidence, prevalence of survival of neuroendocrine neoplasia in England 1995-2018
16. The cost of neuroendocrine tumor patient healthcare: Comparison between advanced economies and emerging and developing economies.
17. Treatments and ongoing monitoring for patients with neuroendocrine tumors, monitored by medical oncologists: Scan comparative data between advanced economies (AE) and emerging and developing economies (EDE).
18. Consensus on molecular imaging and theranostics in neuroendocrine neoplasms
19. Practical recommendations for the management of patients with gastroenteropancreatic and thoracic (carcinoid) neuroendocrine neoplasms in the COVID-19 era
20. Procédure d’hémodialyse chez un patient traité par iode 131
21. Consensus on molecular imaging and theranostics in neuroendocrine neoplasms
22. Practical recommendations for the management of patients with gastroenteropancreatic and thoracic (carcinoid) neuroendocrine neoplasms in the COVID-19 era
23. O42 Incidence of neuroendocrine neoplasms in England 2015–2017
24. Zoom-ing in on natters: Neuroendocrine cancer UK (NCUK) patient support groups during COVID pandemic
25. Survey of challenges in access to diagnostics and treatment for neuroendocrine tumor (NET) patients (SCAN) - UK and Ireland vs global diagnosis of NETs
26. Metachronous neuroendocrine neoplasms in England 2013-2015
27. COVID19 & My Care: NCUK community experience
28. Survey of challenges in access to diagnostics and treatment for neuroendocrine tumor (NET) patients (SCAN): Global disparities in quality healthcare for NETs.
29. Survey of challenges in access to diagnostics and treatment for neuroendocrine tumor (NET) patients (SCAN): Awareness of specialized techniques and latest interventions.
30. Holistic care for NEN patients: updates from the NET Patient Foundation, Mrs Catherine Bouvier (NPF)
31. Incidence and prevalence of neuroendocrine neoplasms reported in England from 2015 to 2017
32. Development of a mobile app for patients with neuroendocrine neoplasms: a collaborative project between United Kingdom NET Society and Neuroendocrine Tumour Patient Foundation
33. Identifying information and support needs for patients with Merkel Cell Carcinoma
34. Unmet needs in the international neuroendocrine tumor (NET) community: Assessment of major gaps from the perspective of patients, patient advocates and NET health care professionals.
35. Prevalence of self-reported side effects in neuroendocrine tumour patients prescribed somatostatin analogues
36. Neuroendocrine Tumour (NET) patients experiences of support in the community setting across the cancer treatment trajectory
37. Incidence and prevalence of neuroendocrine tumours in England
38. 1-Year survival rates for neuroendocrine tumour patients in England
39. Metachronous primary cancers in neuroendocrine tumour patients
40. Cancerous neuroendocrine vs endocrine tumours: broad commonalities and differences
41. NENs, NETs, NECs: Accessing expert care
42. A phase II study of gastrimmune in advanced pancreatic cancer
43. Diviseurs essentiels, composantes essentielles des variétés toriques singulières
44. Système générateur minimal, diviseurs essentiels et $G$-désingularisations de variétés toriques
45. Injection pressure of anesthetics using 30-gauge needles with or without side perforation
46. Practical recommendations for the management of patients with gastroenteropancreatic and thoracic (carcinoid) neuroendocrine neoplasms in the COVID-19 era
47. Incidence and survival of neuroendocrine neoplasia in England 1995-2018: A retrospective, population-based study.
48. [Hemodialysis procedure in a patient treated with radioactive iodine].
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.